Biology and treatment of HTLV-1 associated T-cell lymphomas

Best Practice and Research: Clinical Haematology

Volumn 26, Issue 1, 2013, Pages 3-14

  Tsukasaki, Kunihiro ^a   Tobinai, Kensei ^b  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

ATL; HTLV 1; molecular epidemiology; multi step carcinogenesis; new agent development; subtype classification; treatment strategy

Indexed keywords

ALPHA INTERFERON; BETA CHEMOKINE; BLEOMYCIN; BORTEZOMIB; CALCIUM; CARBOPLATIN; CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; LACTATE DEHYDROGENASE; LENALIDOMIDE; METHOTREXATE; MOGAMULIZUMAB; PANOBINOSTAT; PENTOSTATIN; PRALATREXATE; PREDNISONE; RANIMUSTINE; VINCRISTINE; VINCRISTINE SULFATE; VINDESINE; VORINOSTAT; ZIDOVUDINE;

ADVANCED CANCER; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PREVENTION; CANCER PROGNOSIS; CANCER SCREENING; CHRONIC LYMPHATIC LEUKEMIA; DRUG FATALITY; DRUG INDUCED DISEASE; HAIRY CELL LEUKEMIA; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; INTERSTITIAL PNEUMONIA; MULTIMODALITY CANCER THERAPY; MULTIPLE MYELOMA; NEUTROPENIA; NONHUMAN; PERIPHERAL T CELL LYMPHOMA; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SEZARY SYNDROME; T CELL LEUKEMIA; T CELL LYMPHOMA; THROMBOCYTOPENIA; WATCHFUL WAITING;

ACUTE DISEASE; ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; CHILD; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERFERON-ALPHA; JAPAN; LEUKEMIA-LYMPHOMA, ADULT T-CELL; LYMPHOMA, T-CELL; ZIDOVUDINE;

EID: 84879077149     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2013.04.001     Document Type: Review

References (66)

1. T. Uchiyama, J. Yodoi, and K. Sagawa Adult T-cell leukemia: clinical and hematologic features of 16 cases Blood 50 1977 481 492
2. B.J. Poiesz, F.W. Ruscetti, and A.F. Gazdar Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma Proc Natl Acad Sci U S A 77 1980 7415 7419
3. Y. Hinuma, K. Nagata, and M. Hanaoka Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera Proc Natl Acad Sci U S A 78 10 1981 6476 6480
4. I. Miyoshi, I. Kubonishi, and S. Yoshimoto Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells Nature 294 5843 1981 770 771
5. M. Yoshida, I. Miyoshi, and Y. Hinuma Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease Proc Natl Acad Sci U S A 79 1982 2031 2035
6. A. Gessain, F. Barin, and J.C. Vernant Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis Lancet 2 8452 1985 407 410
7. M. Osame, K. Usuku, and S. Izumo HTLV-I associated myelopathy, a new clinical entity Lancet 1 8488 1986 1031 1032
8. M. Mochizuki, T. Watanabe, and K. Yamaguchi HTLV-I uveitis: a distinct clinical entity caused by HTLV-I Jpn J Cancer Res 83 3 1992 236 239
9. L. LaGrenade, B. Hanchard, and V. Fletcher Infective dermatitis of Jamaican children: a marker for HTLV-I infection Lancet 336 8727 1990 1345 1347
10. K. Takatsuki Adult T-cell leukemia 1994 Oxford University Press, New York Oxford
11. M. Shimoyama Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984-87) Br J Haematol 79 1991 428 437
12. K. Tajima T- and B-cell Malignancy Study Group The 4th nationwide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features Int J Cancer 45 1990 237 243
13. M. Satake, K. Yamaguchi, and K. Tadokoro Current prevalence of HTLV-1 in Japan as determined by screening of blood donors J Med Virol 84 2 2012 327 335
14. M. Hisada, A. Okayama, and S. Shioiri Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I Blood 92 10 1998 3557 3561
15. M. Iwanaga, T. Watanabe, and A. Utsunomiya Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan Blood 116 8 2010 1211 1219
16. Y. Satou, J. Yasunaga, and M. Yoshida HTLV-1 basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells Proc Natl Acad Sci U S A 103 2006 720 725
17. T. Ishida, A. Utsunomiya, and S. Iida Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome Clin Cancer Res 9 2003 3625 3634
18. K. Tsukasaki, H. Tsushima, and M. Yamamura Integration patterns of HTLV-1 provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease Blood 89 1997 948 956
19. E. Wattel, J.P. Vartanian, and C. Pannetier Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy J Virol 69 5 1995 May 2863 2868
20. M. Yamagishi, K. Nakano, and A. Miyake Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers Cancer Cell. 21 1 2012 121 135
21. T. Fujimoto, T. Hata, and T. Itoyama High rate of chromosomal abnormalities in HTLV-I-infected T-cell colonies derived from prodromal phase of adult T-cell leukemia: a study of IL-2-stimulated colony formation in methylcellulose Cancer Genet Cytogenet 109 1 1999 1 13
22. M. Tawara, S.J. Hogerzeil, and Y. Yamada Impact of p53 aberration on the progression of adult T-cell leukemia/lymphoma Cancer Lett 234 2006 249 255
23. K. Tsukasaki, J. Krebs, and K. Nagai Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course Blood 97 12 2001 3875 3881
24. Y.L. Choi, K. Tsukasaki, and M.C. O'Neill A genomic analysis of adult T-cell leukemia Oncogene 26 8 2007 Feb 22 1245 1255
25. H. Sasaki, I. Nishikata, and T. Shiraga Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia Blood 105 3 2005 Feb 1 1204 1213
26. K. Ohshima, E.S. Jaffe, and M. Kikuchi Adult T-cell leukemia/lymphoma S.H. Swerdlow, E. Campo, N.L. Harris, WHO classification of tumour of haemaopoietic and lymphoid tissues 4th ed. 2008 IARC Press Lyon 281 284
27. A.L. Bittencourt, M. da Graças Vieira, and C.R. Brites Adult T-cell leukemia/lymphoma in Bahia, Brazil: analysis of prognostic factors in a group of 70 patients Am J Clin Pathol 128 2007 875 882
28. M. Amano, M. Kurokawa, and K. Ogata New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types J Dermatol 35 5 2008 270 275
29. Y. Sawada, R. Hino, and K. Hama Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lymphoma Blood 117 15 2011 3961 3967
30. T. Watanabe, K. Yamaguchi, and K. Takatsuki Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene J Exp Med 172 3 1990 759 765
31. K. Nosaka, T. Miyamoto, and T. Sakai Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells Blood 99 2 2002 634 640
32. S. Ikeda, S. Momita, and K. Kinoshita Clinical course of human T-lymphotropic virus type I carriers with molecularly detectable monoclonal proliferation of T lymphocytes: defining a low- and high-risk population Blood 82 7 1993 2017 2024
33. K. Tsukasaki, O. Hermine, and A. Bazarbachi Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting J Clin Oncol 27 2009 453 459
34. Lymphoma Study Group Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study Leuk Res 15 1991 81 90
35. H. Katsuya, T. Yamanaka, and K. Ishitsuka Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma J Clin Oncol 30 2012 1635 1640
36. T. Fukushima, S. Nomura, and K. Tsukasaki Characterization of long term survivors and a predictive model for aggressive adult T-cell leukemia-lymphoma (ATL): an ancillary study by the Japan Clinical Oncology Group, JCOG0902A Blood 118 2011 881 [abstract]
37. Y. Takasaki, M. Iwanaga, and Y. Imaizumi Long-term study of indolent adult T-cell leukemia-lymphoma Blood 115 22 2010 4337 4343
38. K. Tsukasaki, K. Tobinai, and M. Shimoyama Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group study (JCOG9109) Int J Hematol 77 2003 164 170
39. Y. Yamada, M. Tomonaga, and H. Fukuda A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukemia-lymphoma (ATL): Japan Clinical Oncology Group (JCOG) Study 9303 Br J Haematol 113 2001 375 382
40. K. Tsukasaki, A. Utsunomiya, and H. Fukuda VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801 J Clin Oncol 25 2007 5458 5564
41. P.S. Gill, W. Harrington, and M.H. Kaplan Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine N Engl J Med 332 1995 1744 1748
42. O. Hermine, D. Blouscary, and A. Gessain Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa N Engl J Med 332 1995 1749 1751
43. K. Tobinai, Y. Kobayashi, and M. Shimoyama Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma (correspondence) N Engl J Med 333 1995 1285 1286
44. A. Datta, M. Bellon, and U. Sinha-Datta Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence Blood 108 3 2006 Aug 1 1021 1029
45. A. Bazarbachi, Y. Plumelle, and J.C. Ramos Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes J Clin Oncol 27 2010 417 423
46. A. Hodson, S. Crichton, and S. Montoto Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma J Clin Oncol 29 35 2011 4696 4701
47. G. Kchour, M. Tarhini, and M.-M. Kooshyar Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL) Blood 113 2009 6528 6532
48. M. Hishizawa, J. Kanda, and A. Utsunomiya Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study Blood 116 8 2010 1369 1376
49. J. Kanda, M. Hishizawa, and A. Utsunomiya Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study Blood 119 9 2012 2141 2148
50. J. Okamura, A. Utsunomiya, and R. Tanosaki Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma Blood 105 2005 4143 4145
51. I. Choi, R. Tanosaki, and N. Uike Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials Bone Marrow Transplant 46 1 2011 116 118
52. T. Ishida, M. Hishizawa, and K. Kato Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study Blood 120 8 2012 1734 1741
53. H. Tamaki, and M. Matsuoka Donor-derived T-cell leukemia after bone marrow transplantation N Engl J Med 354 16 2006 Apr 20 1758 1759
54. N. Arima, H. Mizoguchi, and S. Shirakawa Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma [Article in Japanese] Gan To Kagaku Ryoho 26 5 1999 619 629
55. K. Tobinai, N. Uike, and Y. Saburi Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma Int J Hematol 77 5 2003 512 517
56. H. Hasegawa, Y. Yamada, and K. Tsukasaki LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway Leukemia 25 4 2011 575 587
57. T.A. Waldmann Multichain interleukin-2 receptor: a target for immunotherapy in lymphoma J Natl Cancer Inst 81 1989 914 923
58. T.A. Waldmann, J.D. White, and J.A. Carrasquillo Radioimmunotherapy of interleukin-2Ra-expressing adult T-cell leukemia with yttrium-90-labeled anti-Tac Blood 86 1996 4063 4075
59. J.L. Berkowitz, J.E. Janik, and D.M. Stewart Phase II trial of daclizumab in human T-cell lymphotropic virus type-1 (HTLV-1)-associated adult T-cell leukemia/lymphoma (ATL) J Clin Oncol 28 2010 7s [suppl; abstr 8043]
60. D. O'Mahony, J.C. Morris, and M. Stetler-Stevenson EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies Clin Cancer Res 15 7 2009 2514 2522
61. K. Yamamoto, A. Utsunomiya, and K. Tobinai Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma J Clin Oncol 28 9 2010 1591 1598
62. T. Ishida, T. Joh, and N. Uike Multicenter phase II study of KW-0761, a defucosylated anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma (ATL) Blood 116 2010 128a [abstract 285]
63. N. Uike, M. Ogura, and Y. Imaizumi Multicenter phase 1 dose-escalation study of lenalidomide (CC-5013) in relapsed patients with advanced adult T-cell leukemia-lymphoma or peripheral T-cell lymphoma Blood 120 2012 2737 [abstract]
64. Y. Satou, K. Nosaka, and Y. Koya Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro Leukemia 18 2004 1357 1363
65. Owen A. O'Connor, Barbara Pro, and Lauren Pinter-Brown PROPEL: a multi-center phase 2 open-label study of pralatrexate (PDX) with vitamin B12 and folic acid supplementation in patients with replapsed or refractory peripheral T-cell lymphoma Blood (ASH Annual Meeting Abstracts) 112 2008 261
66. A.G. Marneros, M.E. Grossman, and D.N. Silvers Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions Blood 113 25 2009 6338 6341